Fig. 3From: Elevated circulating level of β-aminoisobutyric acid (BAIBA) in heart failure patients with type 2 diabetes receiving sodium-glucose cotransporter 2 inhibitors The least squares means of plasma β-aminoisobutyric acid (BAIBA) concentration after inverse probability of treatment weighting. SGLT2i, sodium-glucose cotransporter inhibitor; BAIBA, β-aminoisobutyric acidBack to article page